Hadis Honarvar
Hadis Honarvar
Unknown affiliation
Verified email at bms.uu.se
Title
Cited by
Cited by
Year
HAHAHA, HEHEHE, HIHIHI, or HKHKHK: Influence of Position and Composition of Histidine Containing Tags on Biodistribution of [99mTc(CO)3]+-Labeled …
C Hofström, M Altai, H Honarvar, J Strand, J Malmberg, ...
Journal of medicinal chemistry 56 (12), 4966-4974, 2013
592013
The effect of mini-PEG-based spacer length on binding and pharmacokinetic properties of a 68Ga-labeled NOTA-conjugated antagonistic analog of bombesin
Z Varasteh, U Rosenström, I Velikyan, B Mitran, M Altai, H Honarvar, ...
Molecules 19 (7), 10455-10472, 2014
562014
Feasibility of affibody molecule-based PNA-mediated radionuclide pretargeting of malignant tumors
H Honarvar, K Westerlund, M Altai, M Sandström, A Orlova, V Tolmachev, ...
Theranostics 6 (1), 93, 2016
532016
ADAPT, a novel scaffold protein-based probe for radionuclide imaging of molecular targets that are expressed in disseminated cancers
J Garousi, S Lindbo, J Nilvebrant, M Åstrand, J Buijs, M Sandström, ...
Cancer research 75 (20), 4364-4371, 2015
502015
Influence of Macrocyclic Chelators on the Targeting Properties of 68Ga-Labeled Synthetic Affibody Molecules: Comparison with 111In-Labeled Counterparts
J Strand, H Honarvar, A Perols, A Orlova, RK Selvaraju, AE Karlström, ...
PLoS One 8 (8), e70028, 2013
492013
Imaging of HER3-expressing xenografts in mice using a 99m Tc (CO) 3-HEHEHE-Z HER3: 08699 affibody molecule
A Orlova, M Malm, M Rosestedt, Z Varasteh, K Andersson, RK Selvaraju, ...
European journal of nuclear medicine and molecular imaging 41 (7), 1450-1459, 2014
482014
Imaging of platelet-derived growth factor receptor β expression in glioblastoma xenografts using affibody molecule 111In-DOTA-Z09591
V Tolmachev, Z Varasteh, H Honarvar, SJ Hosseinimehr, O Eriksson, ...
Journal of Nuclear Medicine 55 (2), 294-300, 2014
482014
Feasibility of affibody-based bioorthogonal chemistry–mediated radionuclide pretargeting
M Altai, A Perols, M Tsourma, B Mitran, H Honarvar, M Robillard, ...
Journal of Nuclear Medicine 57 (3), 431-436, 2016
462016
Influence of DOTA Chelator Position on Biodistribution and Targeting Properties of 111In-Labeled Synthetic Anti-HER2 Affibody Molecules
A Perols, H Honarvar, J Strand, R Selvaraju, A Orlova, ...
Bioconjugate chemistry 23 (8), 1661-1670, 2012
372012
Influence of histidine-containing tags on the biodistribution of ADAPT scaffold proteins
S Lindbo, J Garousi, M Åstrand, H Honarvar, A Orlova, S Hober, ...
Bioconjugate chemistry 27 (3), 716-726, 2016
342016
Design, preparation, and characterization of PNA-based hybridization probes for affibody-molecule-mediated pretargeting
K Westerlund, H Honarvar, V Tolmachev, A Eriksson Karlström
Bioconjugate chemistry 26 (8), 1724-1736, 2015
342015
Incorporation of a Triglutamyl Spacer Improves the Biodistribution of Synthetic Affibody Molecules Radiofluorinated at the N-Terminus via Oxime Formation with 18F …
D Rosik, A Thibblin, G Antoni, H Honarvar, J Strand, RK Selvaraju, M Altai, ...
Bioconjugate chemistry 25 (1), 82-92, 2014
292014
Increasing the net negative charge by replacement of DOTA chelator with DOTAGA improves the biodistribution of radiolabeled second-generation synthetic affibody molecules
K Westerlund, H Honarvar, E Norrstrom, J Strand, B Mitran, A Orlova, ...
Molecular pharmaceutics 13 (5), 1668-1678, 2016
272016
Comparative evaluation of affibody molecules for radionuclide imaging of in vivo expression of carbonic anhydrase IX
J Garousi, H Honarvar, KG Andersson, B Mitran, A Orlova, J Buijs, ...
Molecular pharmaceutics 13 (11), 3676-3687, 2016
262016
Evaluation of the first 44Sc-labeled Affibody molecule for imaging of HER2-expressing tumors
H Honarvar, C Müller, S Cohrs, S Haller, K Westerlund, AE Karlström, ...
Nuclear medicine and biology 45, 15-21, 2017
242017
Imaging of CAIX-expressing xenografts in vivo using 99mTc-HEHEHE-ZCAIX: 1 affibody molecule
H HONARvAR, J Garousi, E Gunneriusson, I HöIDéN-GUTHENbERG, ...
International journal of oncology 46 (2), 513-520, 2015
232015
188Re-ZHER2: V2, a promising affibody-based targeting agent against HER2-expressing tumors: preclinical assessment
M Altai, H Wållberg, H Honarvar, J Strand, A Orlova, Z Varasteh, ...
Journal of Nuclear Medicine 55 (11), 1842-1848, 2014
232014
Position for site-specific attachment of a DOTA chelator to synthetic affibody molecules has a different influence on the targeting properties of 68Ga-compared to 111in-labeled …
H Honarvar, J Strand, A Perols, A Orlova, RK Selvaraju, AE Karlström, ...
Molecular imaging 13 (10), 7290.2014. 00034, 2014
222014
Evaluation of 99mTc-ZIGF1R:4551-GGGC affibody molecule, a new probe for imaging of insulin-like growth factor type 1 receptor expression
B Mitran, M Altai, C Hofström, H Honarvar, M Sandström, A Orlova, ...
Amino acids 47 (2), 303-315, 2015
202015
Selection of an optimal cysteine-containing peptide-based chelator for labeling of affibody molecules with 188Re
M Altai, H Honarvar, H Wållberg, J Strand, Z Varasteh, M Rosestedt, ...
European journal of medicinal chemistry 87, 519-528, 2014
202014
The system can't perform the operation now. Try again later.
Articles 1–20